Zenklusen J C, Oshimura M, Barrett J C, Conti C J
University of Texas M.D. Anderson Cancer Center Science Park, Research Division, Smithville 78957.
Oncogene. 1994 Oct;9(10):2817-25.
Alterations in oncogenes and tumor suppressor genes (TSG) are considered to be critical steps in oncogenesis. However information on putative TSG involved in the development of squamous cell carcinomas (SCC) is very limited. In this study we confirmed the existence of a tumor suppressor gene (TSG) on human chromosome 7 (hchr 7) that suppresses the tumorigenicity of squamous cell carcinomas (SCCs). We injected seven clones of CH72 cells (a murine SCC-derived cell line) bearing a hchr 7 (CH72/hchr 7) introduced by microcell fusion, two clones bearing human chromosome 12 (CH72/hchr 12) and parental CH72 cells into athymic Balb/c nude mice. The sizes of the tumors were determined twice a week until tumors reached 12 mm diameter. In situ hybridization for centromeric repetitive sequences of the transferred chromosomes were performed on the cell lines injected and the tumors arising after the injection. Southern blots and polymerase chain reaction (PCR) amplifications of near terminal sequences and (CA) microsatellite repeats were done to test the integrity of the introduced chromosomes. Five out of seven CH72/hchr 7 clones had a twofold and threefold longer latency periods than CH72 cells. The remaining CH72/hchr 7 clones (MF 6 and 13 no. 4) had latency periods similar to that of parental CH72; MF 6 had a deletion in the introduced chromosome 7 involving q31.3-q31.3, whereas the other hybrid (MF 13 no. 4) seemed to have an intact hchr 7. Tumor-derived cells from CH72/hchr 7 hybrids with a delayed latency had lost centromeric and telomeric sequences of Chr 7. In contrast, tumors derived from the MF 6 and MF 13 no. 4 as well as the CH72/hchr 12 clones retained the introduced human chromosome as shown by chromosome 7 or 12 centromeric and telomeric sequences. These results indicate that the tumorigenicity of CH72 murine SCC cells was suppressed by hchr 7 and that the CH72/hchr 7 regain the tumorigenic phenotype after loss of the introduced chromosome, suggesting the presence of a TSG on hchr 7.
致癌基因和肿瘤抑制基因(TSG)的改变被认为是肿瘤发生过程中的关键步骤。然而,关于参与鳞状细胞癌(SCC)发生发展的假定肿瘤抑制基因的信息非常有限。在本研究中,我们证实了人类7号染色体(hchr 7)上存在一个肿瘤抑制基因(TSG),它能抑制鳞状细胞癌(SCC)的致瘤性。我们将通过微细胞融合导入hchr 7的7个CH72细胞克隆(一种源自小鼠SCC的细胞系)、2个携带人类12号染色体的克隆(CH72/hchr 12)以及亲本CH72细胞注射到无胸腺的Balb/c裸鼠体内。每周测量两次肿瘤大小,直至肿瘤直径达到12毫米。对注射的细胞系和注射后产生的肿瘤进行转移染色体着丝粒重复序列的原位杂交。进行Southern印迹分析以及对近末端序列和(CA)微卫星重复序列的聚合酶链反应(PCR)扩增,以检测导入染色体的完整性。7个CH72/hchr 7克隆中有5个的潜伏期比CH72细胞长两倍到三倍。其余的CH72/hchr 7克隆(MF 6和13号4号)的潜伏期与亲本CH72相似;MF 6导入的7号染色体在q31.3 - q31.3区域存在缺失,而另一个杂种(MF 13号4号)似乎具有完整的hchr 7。潜伏期延迟的CH72/hchr 7杂种的肿瘤衍生细胞丢失了7号染色体的着丝粒和端粒序列。相反,如7号或12号染色体着丝粒和端粒序列所示,源自MF 6和MF 13号4号以及CH72/hchr 12克隆的肿瘤保留了导入的人类染色体。这些结果表明,hchr 7抑制了CH72小鼠SCC细胞的致瘤性,并且CH72/hchr 7在导入的染色体丢失后恢复了致瘤表型,提示hchr 7上存在一个肿瘤抑制基因。